Rafferty Asset Management, LLC Vbi Vaccines Inc Transaction History

Rafferty Asset Management, LLC

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 12, 2022	SELL	$0.66 - $1.81 $688,315 - $1.89 Million	-1,042,903 Reduced 95.25%	51,966 $42,000
Q1 2022 May 13, 2022	BUY	$1.27 - $2.47 $315,299 - $613,219	248,267 Added 29.33%	1,094,869 $1.82 Million
Q4 2021 Feb 10, 2022	BUY	$2.21 - $3.22 $752,352 - $1.1 Million	340,431 Added 67.26%	846,602 $1.98 Million
Q3 2021 Nov 10, 2021	SELL	$2.8 - $3.72 $28,294 - $37,590	-10,105 Reduced 1.96%	506,171 $1.57 Million
Q2 2021 Aug 10, 2021	SELL	$2.61 - $4.17 $1.34 Million - $2.15 Million	-515,245 Reduced 49.95%	516,276 $1.73 Million
Q1 2021 May 10, 2021	BUY	$2.91 - $4.32 $2.18 Million - $3.23 Million	748,017 Added 263.85%	1,031,521 $3.21 Million
Q4 2020 Feb 10, 2021	SELL	$2.15 - $3.5 $757,750 - $1.23 Million	-352,442 Reduced 55.42%	283,504 $780,000
Q3 2020 Nov 13, 2020	BUY	$2.77 - $6.17 $1.76 Million - $3.92 Million	635,946 New	635,946 $1.82 Million

688K

Ticker VBIV
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 258,256,992
Market Cap $5.17M
Description
VBI Vaccines Inc., a biopharmaceutical company, develops and sells vaccines for the treatment of infectious diseases and immuno-oncology. The company offers Sci-B-Vac, a prophylactic hepatitis B (HBV) vaccine. It also engages in the development of VBI-2601 (BRII-179), an immunotherapeutic candidate for the treatment of chronic HBV infection. The...

Get notified when there are updates to the investment portfolio of Rafferty Asset Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Rafferty Asset Management, LLC with notifications on news.